U.S. government plans to stockpile anthrax vaccine

03/15/2004 | Washington Post (tiered subscription model), The

The U.S. government plans to stockpile enough anthrax vaccine to treat 27 million people in case of a terrorist attack, with the supply to be spread out among several areas of the country. The purchase is expected to change the current orphan-drug type status of anthrax and make the purchases numerous enough to provide drug makers with an incentive to develop a modern version of the vaccine.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC